Ph3 open label study of TROP2-positive in mNSCLC (Tropion-Lung17)
Phase III Clinical Trial
A Phase III Randomised Open-Label Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung17 D763QC00001)
Participating Locations